Abstract
Background: Coronavirus disease 2019 (COVID-19) has been the most important global issue since December 2019. Although the clinical course of COVID-19 is known to be milder in children than in adults, associated hospitalizations among children have increased since the emergence of contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and the achievement of a high vaccination rate in adults. Considering these global and domestic situations, we believe that risk stratification in children with COVID-19 is urgently needed for decision making regarding hospitalization priority in children infected with SARS-CoV-2 and vaccination priority against COVID-19.
Methods: This systematic review and meta-analysis was performed by comprehensively searching the PubMed, EMBASE, Scopus and KoreaMed databases through August 25, 2021. The criteria for enrollment were “severe COVID-19” as poor outcomes (intensive care unit admission, invasive mechanical ventilation, and/or death) and underlying comorbidities before SARS-CoV-2 infection.
Results: Among 872 screened studies, 17 articles were included in the systematic review, and 10 articles were included in the meta-analysis. Neonate (risk ratio [RR], 2.69; 95% confidence interval [CI], 1.83-3.97), prematurity in young infants (RR, 2.00; 95% CI, 1.63-2.46), obesity (RR, 1.43; 95% CI, 1.24-1.64), diabetes (RR, 2.26; 95% CI, 1.95-2.62), chronic lung disease (RR, 2.62; 95% CI, 1.71-4.00), heart disease (RR, 1.82; 95% CI, 1.58-2.09), neurologic disease (RR, 1.18; 95% CI, 1.05-1.33), and immunocompromised status (RR, 1.44; 95% CI, 1.01-2.04) were significant risk factors for severe COVID-19 in children. In the subgroup analysis, age younger than 3 months (RR, 0.26; 95% CI, 0.11-0.66), asthma (RR, 1.08; 95% CI, 0.98-1.20), and neurodevelopmental disorders (RR, 0.88; 95% CI, 0.75-1.04) were not risk factors for severe COVID-19.
Conclusion: Children with comorbidities such as obesity, diabetes, heart disease, chronic lung diseases other than asthma, seizure disorders, and an immunocompromised status had a high prevalence of severe COVID-19. Neonate and premature infants had a high risk of severe COVID-19. Defining the high-risk group for severe COVID-19 could help to guide hospital admission and priority for vaccination against SARS-CoV-2.
Keywords: COVID-19; Children; Critical Illness; Meta-Analysis; Risk Factor.
【저자키워드】 COVID-19, Meta-analysis, Critical illness, children, risk factor, 【초록키워드】 coronavirus disease, Meta-analysis, SARS-CoV-2, Asthma, Coronavirus disease 2019, coronavirus, vaccination, Risk factors, intensive care, severe COVID-19, Hospitalization, Decision making, SARS-COV-2 infection, obesity, variant, Comorbidities, systematic review, Lung disease, Comorbidity, risk, diabetes, outcome, risk factor, database, variants, Infant, Prevalence, risk stratification, Adults, Clinical course, Neonate, hospitalizations, death, Immunocompromised, age, Premature, Hospital admission, disease, Admission, intensive care unit admission, Invasive mechanical ventilation, chronic lung disease, Seizure, risk ratio, Prematurity, heart disease, criteria, high risk, chronic lung diseases, acute respiratory syndrome, Factor, Enrollment, 95% CI, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, disorders, 95% confidence interval, achievement, priority, help, subgroup analysis, article, disorder, contagious, vaccination rate, neurologic, immunocompromised status, was performed, screened, diabete, children with COVID-19, infected with SARS-CoV-2, 【제목키워드】 review, Factor,